Latest Conference Articles

The University of Michigan has been synonymous with the flu vaccine since its first usage and Arnold Monto, MD, says work continues to make the vaccine as safe and effective as possible.

Amesh Adalja, MD, FACP, of the University of Pittsburgh Medical Center, was one of several speakers at IDWeek 2014 in Philadelphia discussing the recent Ebola outbreak in West Africa.

Tina Tan, MD, offers insights on preparations for the approaching cold and flu season, which could be one of the worst in years.

Stephen Gluckman, MD, talks about the challenges facing doctors who treat patients infected with Ebola or Enterovirus D68. He also discusses issues facing clinicians as cold and flu season gets underway.

At IDWeek 2014, one of the physicians from the admitting hospital reviewed the facts of the case, outlined the testing strategy utilized during the epidemiologic investigation into the causes of the paralysis, discussed possible factors suggesting an association with EV-D68, and provided an update on the prognosis of the affected children.

As more children were admitted to Children's Mercy Hospital in Kansas City, the staff knew something was wrong. One doctor gave her impressions of that time during IDWeek 2014 in Philadelphia.

The symptoms and tests for Enterovirus were discussed during a press conference at IDWeek 2014 in Philadelphia.

Pediatricians' approach to discussing and recommending HPV vaccination with parents and adolescents varies widely, and can have a significant impact on parents' decision to vaccinate.

Kathryn M. Edwards, MD, of Vanderbilt University, discusses the history of HPV treatment.

Jeff Duchin, MD, of the Seattle and King County Departments of Public Health, discusses enterovirus and the relationship with treatment during cold and flu season.

In treatment-naive patients with genotype 4 HCV, treatment with daclatasvir in combination with peginterferon alfa/ribavirin resulted in higher SVR12 rates than treatment with peginterferon alfa/ribavirin alone.

Bruce Ribner, MD, a doctor at Emory University Hospital, discusses the treatment of patients with Ebola at the Atlanta hospital

Results from a study of herpes zoster incidence following periods of acute stress in a large cohort of patients suggest the conventional wisdom on this subject may be wrong.

Results from a 12-week study show that treatment with once-daily, single-entity hydrocodone formulated with abuse-deterrent properties is safe and effective compared with placebo.

Although methadone accounts for only 2% of opioid prescriptions, it caused nearly one in 3 prescription opioid overdose deaths in 2012, a 6-fold increase from 2009, according to the CDC.

Because there is no objective test for pain, and because each patient's experience of his or her painful condition is subjective and unique, physicians who treat these patients must process a variety of symptoms, signs, and cues to determine whether they can trust their patient's narrative.

Despite the best tests, procedures, and medications that modern medicine has to offer, chronic pain is still a major cause of disability. Could a more holistic approach to pain management lead to improved quality of life for individuals with chronic pain?

Study results show that patients diagnosed with fibromyalgia often discontinue treatment. Those that do not frequently augment their initial treatment regimen with one or more additional medications, including some that are not recommended by current guidelines.

The patient-reported painDETECT questionnaire has been shown to accurately and reliably identify neuropathic pain across a range of conditions.

Knowledge of dietary supplement properties, uses, and contraindications is highly relevant to any health care practitioner that treats patients with chronic pain. Data shows that the top four reasons for supplement use are back pain, neck pain, joint pain, and arthritis.

Research indicates that there are probable etiologies of low back pain that can affect treatment outcome and that ignoring pain can possibly cause chronic neurological changes.

Researchers are learning more about the ways in which gut microbiota interact with the central nervous system and the role this can play in pain management.

Although the underlying mechanisms are not fully understood, opioid-induced hyperalgesia occurs in some patients on higher doses of opioids. Treatment options include reducing, rotating, or completely tapering the opioid regimen.

Paul Wicks, PhD, comments on physicians' acceptance of technological evolution in data collection at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Paul Wicks, PhD, discusses the surge in Internet-savvy patients at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Nancy Chiaravalloti, PhD, shares how cognitive function impacts patients with progressive multiple sclerosis at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Don Mahad, MD, PhD, discusses his research's focus of protecting nerve cells at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Alasdair Coles, MD, University of Cambridge, shares his thoughts on the efficacy of alemtuzumab for patients with multiple sclerosis (MS) at the 2014 Joint ACTRIMS-ECTRIMS Meeting in Boston.

Assessment of long-term data on treatment utility demonstrates the effectiveness and cost-effectiveness of interferon-beta and glatiramer acetate for multiple sclerosis.

Treatment with Sativex oromucosal spray produces significant reductions in spasticity in patients with multiple sclerosis (MS) compared with placebo, but researchers reported no significant difference between the two in neurophysiologic measures.